Yellow fever vaccine study for certain people with HIV
Part of Immune system & allergy, Infections clinical trials.
This trial checks whether a yellow fever vaccine is safe and works well in adults with HIV who have relatively healthy immune function. It may help doctors understand the best way to protect people with HIV who have never had this vaccine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be age 18 to under 60
- You are either living with HIV, or you are HIV-negative
- If you have HIV: your CD4 count is above 200 (measured within the last 6 months) or you have an up-to-date CD4 result that meets an allowed exception
- You must never have had a yellow fever vaccine before
- You must be able and willing to sign the study consent and follow study visits
- You cannot be pregnant, and you must not have certain serious ongoing health problems or immune-suppressing medicines
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well the body’s protection against yellow fever lasts 10 years after the first vaccine. It compares people living with HIV (who are on stable treatment) with people who are HIV negative, to learn whether immunity stays strong over time.
This study tests a new injectable drug (VH4011499) for safety and how the body processes it. It's for healthy adults without HIV, and participants will get either the study drug or a placebo (an inactive shot).
This trial studies how well the yellow fever vaccine “17D” stimulates the immune system (the body’s germ-fighting response) in adults who were vaccinated with 17D years ago. It may help researchers understand whether a prior vaccination still provides protection and how strong the immune response is.
This study looks at how your immune system “remembers” the yellow fever vaccine over time. It may help researchers understand long-term immune protection and how it varies between people.
This study looks at how your body's immune system responds to the yellow fever vaccine. It may help researchers understand how well the vaccine protects people.
This trial tests a new yellow fever vaccine in young children. It will see if the vaccine is safe and produces a good immune response, including when given with the MMR vaccine.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.